About Biocompatible Fabric - The
Future Of Medical Textiles?
Healthcare fabrics is one of the fastest growing
segments of the medical textile industry. In fact, 2020 saw the global medical
textiles market size valued at USD 24.70 billion, with forecasts predicting its
continued expansion at a CAGR of 4.5% to 2028.
This staggering growth is owing to the increased
need for better wound closure devices that feature faster healing times and
lower incidences of failure and infection, compounded by a growing demand for
better healthcare services and more efficient medical treatments.
The largest share of 2020’s global revenue came from
the nonwoven segment with a 65% hold, and a prediction for the fastest growth in
the forecast period. The non-implantable goods segment, meanwhile, is expected
to register a revenue based CAGR of 4.4%, with demand driven by an increasing
number of surgeries and subsequently a growing need to protect wounds and
stitches from the external environment.
Newer approaches and innovations in surgical
adhesives and sealants continue to grow, with both momentum and market share
Many of these developments – polymer-based
nanofabrication, is one example – have sought to address the issues typically
associated with traditional medical fabrics (such as their inability to prevent
bacteria from accessing the wound site, which can lead to infection), while
simultaneously providing additional clinical benefits. As the use of
nanomaterials in biomedical applications gains widespread adoption, yearly
market revenue is expected to increase. This will subsequently break down the
primary barriers to take up – cost and scalability – as further research is
conducted and development processes are streamlined.
Developments in biocompatibility
Polymeric nanomaterials, for example, have been
researched extensively for a wide range of clinical applications, such as in
drug delivery systems and tissue-engineering scaffolds, thanks to their
biocompatibility and non-reactivity.
Biocompatibility challenges with medical fabrics
Biocompatible fabrics are important tools for the
healthcare industry, used widely within diagnostics applications, wound care
management, blood filters, and even implantable devices. To be deemed safe for
use, these fabrics must pass all relevant biocompatibility tests and must be
non-cytotoxic, non-hemolytic, non-pyrogenic, and show no sensitisation. Download
this whitepaper to find out what goes into manufacturing biocompatible fabrics
for the medical industry, including the complex washing and testing process.
According to Piotr Gasiorczyk business development
manager at leading manufacturer of precision fabrics Sefar Inc: “Today,
biocompatible medical fabric is mostly used for high-precision applications,
such as heart surgery. Many of these product advancements come from unique
applications or unique customer requests which allow for a wider range of use of
The use of biocompatible fabrics requires careful
navigation of certain certification and regulations.
Its applications include implants, medical devices,
blood filtration, security filters into infusion sets, and applications for cell
In the coming years, there will be an ever-growing
need for more biocompatible wound healing devices that promote robust patient
recovery while preventing the need for expensive interventions to treat
infections. Recent innovations will markedly improve the quality of surgical
adhesives and sealants, which are important segments already capturing
significant shares of the wound care market.